The clinical characters of paratesticular rhabdomyosarcoma in children

doi:10.3877/cma.j.issn.2095-655X.2019.03.012

Abstract

Abstract:

Objective

To explore the clinical characters and treatment of paratesticular rhabdomyosarcoma (RMS) in children.

Methods

The clinical data of a child patient with paratesticular RMS was retrospectively analyzed and the related literatures were reviewed.

Results

The patient presented with a progressively enlarging mass in left scrotum. Biochemical test, immunologic test, tumor marker showed no abnormalities. Ultrasound demonstrated a solid lesion in the left scrotum with rich blood supply signals inside. Enhanced magnetic resonance showed the same result as ultrasound. Radical left testicular resection was performed. Pathological diagnosis was paratesticular RMS with positive result of Desmin and Myogenin. A painless mass was found in the left scrotum on the third day after operation, then left scrotum resection was performed. VAC chemotherapy was used after operation. Follow-up for 8 months, the patient survived with tumor free.

Conclusions

The paratesticular RMS can present as a mass in scrotum and is easily considered to be carcinoma of testis because of its location. Correct diagnosis and reasonable treatments can be made by pathologic examination after radical resection.

Key words: Child, Rhabdomyosarcoma, Paratesticular, Diagnosis

Pengpeng Zhao, Jianhua Huang, Fuxiang Lin, Zhanping Xu. The clinical characters of paratesticular rhabdomyosarcoma in children[J]. Chinese Journal of Diagnostics(Electronic Edition), 2019, 07(03): 193-197.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2019.03.012

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2019/V07/I03/193

Figures/Tables 3

References 19

[1]	Simon JH, Paulino AC, Ritchie JM，et al.Presentation，prognostic factors and patterns of failure in adult rhabdomyosarcoma[J]．Sarcoma，2003，7(1):1-7.
[2]	Ries LA, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents：United States SEER Program 1975-1995，National Cancer Institute，SEER Program [J]．NIH Pub，1999:99-4649.
[3]	Kaefer M, Rink RC.Genitourinary rhabdomyosarcoma：treatment options [J]. Urol Clin North Am，2000，27(3):471-487.
[4]	Skapek SX, Anderson J, Barr FG，et al.PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma：a children's oncology group report [J]．Pediatr Blood Cancer，2013，60(9):1411-1417.
[5]	Barr FG, Smith LM, Lynch JC，et al.Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-Ⅲ trial：a report from the Children′s Oncology Group [J]．J Mol Diagn，2006，8(2):202-208.
[6]	Davicioni E, Anderson MJ, Finckenstein FG, et al. Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis：a report from the Children′s Oncology Group [J]．Am J Pathol，2009，174 (2):550-564.
[7]	Chen X, Stewart E, Shelat AA，et al.Targeting oxidative stress in embryonal rhabdomyosarcoma [J]．Cancer Cell，2013，24(6):710-724.
[8]	Mosquera JM, Sboner A, Zhang L, et al. Recurrent NCOA2 gene rearrangements in congenital/infantiIe spindle cell rhabdomyosarcoma[J]．Genes Chromosomes Cancer，2013，52(6):538-550.
[9]	Shern JF, Yohe ME, Khan J．Pediatric rhabdomyosarcoma [J]．Crit Rev Oneog，2015，20(3-4):227-243.
[10]	蔡文超，罗敏，包强．儿童阴囊内睾丸外肿物的CT和MRI表现[J]．影响诊断与介入放射学，2017，26(4):287-291.
[11]	Norman G, Fayter D, Lewis-Light K，et al.An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma：systematic review [J]．BMJ Open，2015，5(1):e006030.
[12]	李俊萍，边美玲，董爱华．胃原发胚胎性横纹肌肉瘤临床诊断学特征及文献复习[J/CD]．中华诊断学电子杂志，2016，4(4):245-248.
[13]	童刚领，孙晓非，甄子俊，等．p-mTOR和p-4EBPl在横纹肌肉瘤组织中的表达及其临床意义[J]．中国肿瘤临床，2011，38(8):447-451.
[14]	Kodet R, Newton WA Jr, Hamoudi AB，et al.Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features：a report of the Intergroup Rhabdomyosarcoma Study [J]．Am J Surg Pathol，1993，17(5):443-453.
[15]	Qualman S, Lynch J, Bridge J，et al.Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma ：a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group [J]．Cancer，2008，113(11):3242-3247.
[16]	Crist WM, Anderson JR, Meza JL，et al.Intergroup rhabdomyosarcoma study-Ⅳ：results for patients with nonmetastatic disease [J]．J Clin Oncol，2001，19(12):3091-3102.
[17]	Stevens MC, Rey A, Bouvet N，et al.Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence：third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89[J]．J Clin Oncol，2005，23(12):2618-2628.
[18]	Ferrari A, Casanova M, Massimino M, et al. The management of paratesticular rhabdomysarcoma：a single institutional experience with 44 consecutive children[J]．J Urol，1998，159(3):1031-1034.
[19]	Wiener ES, Anderson JR, Ojimba JI，et al.Controversies in the management of paratesticular rhabdomyosarcoma：is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? [J]. Semin Pediatr Surg，2001，10(3):146-152.

Please choose a citation manager

Content to export